Rapid, Non-Invasive Test Identifies Gastric Cancer Risk in 15 Minutes
By HospiMedica International staff writers Posted on 09 Jun 2023 |
Atrophic gastritis, caused by Helicobacter pylori infection or autoimmune diseases, can elevate the risk of gastric and esophageal cancers, along with impairing the absorption of vitamin B12, calcium, iron, zinc, and magnesium. Now, a rapid test allows for fast diagnosis of and screening for Helicobacter pylori, atrophic gastritis with related risks, and elevated stomach acid output in both symptomatic and asymptomatic patients.
BIOHIT HealthCare (Helsinki, Finland) is rolling out its innovative GastroPanel Quick Test - a revolutionary approach to the diagnosis of Helicobacter pylori infection, atrophic gastritis, and high acid outputs in symptomatic as well as asymptomatic patients. The GastroPanel Quick Test is an advanced version of the unique Biohit GastroPanel examination. This rapid, non-invasive test investigates Helicobacter pylori infection and three stomach-specific biomarkers – pepsinogen I, pepsinogen II, and gastrin-17 – within just 15 minutes. This tool can assist clinicians in expediting patient referrals for endoscopy at a lower cost, which may result in earlier cancer detection and interventions via surveillance programs.
The GastroPanel Quick Test utilizes the immunoassay method to identify GastroPanel biomarkers from EDTA plasma, enabling the first-line diagnosis of dyspeptic patients and screening of symptomatic and asymptomatic patients more conveniently than ever before. Besides reducing costs and eliminating needless clinical visits, the GastroPanel Quick Test considerably enhances patient safety, as it accelerates referrals for further examinations, treatments, and follow-ups.
Related Links:
BIOHIT HealthCare
Latest Point of Care News
- Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing
- Point of Care HIV Test Enables Early Infection Diagnosis for Infants
- Whole Blood Rapid Test Aids Assessment of Concussion at Patient's Bedside
- New Generation Glucose Hospital Meter System Ensures Accurate, Interference-Free and Safe Use
- Unique Quantitative Diagnostic System Enables Immediate Diagnosis and Treatment at POC
- POC Myocardial Infarction Test Delivers Results in 17 Minutes
- Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury